Celltrion resubmits Rituxan candidate in US, Herceptin version to follow

Celltrion resubmits Rituxan candidate in US, Herceptin version to follow

Submitted by admin on May 30, 2018 - 8:29pm
Source: 
Biopharma Reporter
News Tags: 
Celltrion
Rituxan
biosimilars
FDA
Herceptin
Roche
Biogen
CT-P10
Headline: 
Celltrion resubmits Rituxan candidate in US, Herceptin version to follow
snippet: 

Celltrion has resubmitted its Rituxan biosimilar candidate for approval following the US FDA’s rejection in April.

Do Not Allow Advertisers to Use My Personal information